Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Ovary Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07340164
What this trial is testing

Trastzumab Deruxtecan Versus SOC in Recurrent Ovarian That Progressed on Prior PARP Inhibitor Therapy

Who this might be right for
Ovarian CancerOvarian Carcinoma, RecurrentOvarian Cancer Metastatic Recurrent+1 more
Yonsei University 116
Not applicableNot Yet RecruitingNCT06558019
What this trial is testing

Exosome-based OCS Scores for Predicting Ovarian Cancer Recurrence

Who this might be right for
Ovarian Cancer
Lei Li 509
Testing effectiveness (Phase 2)Looking for participantsNCT07171528
What this trial is testing

Secondary Cytoreductive Surgery After Chemotherapy for Recurrent Epithelial Ovarian Cancer

Who this might be right for
Ovarian Cancer
National Cancer Center, Korea 80
Not applicableStudy completedNCT03823833
What this trial is testing

Oocyte Freezing for Fertility Preservation in Benign Ovarian Tumors

Who this might be right for
EndometriosisDermoid CystMucinous Cyst
University Hospital, Lille 82
Testing effectiveness (Phase 2)WithdrawnNCT05736952
What this trial is testing

Oral Topotecan Combined With Anlotinib in Patients With Platinum-resistant Recurrent Ovarian Cancer

Who this might be right for
Platinum-resistant Ovarian Cancer
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Testing effectiveness (Phase 2)Looking for participantsNCT06769152
What this trial is testing

A Phase II Clinical Study to Evaluate the Efficacy and Safety of HLX43 (Anti-PD-L1 ADC) in Patients With Advanced Gynecological Malignant Tumors

Who this might be right for
Cervical CancerOvarian Cancer
Shanghai Henlius Biotech 190
Early research (Phase 1)Not Yet RecruitingNCT07664735
What this trial is testing

Evaluate the Safety and Efficacy of OPB-201 in Recurrent Endometrial and Platinum-resistant Ovarian Cancer.

Who this might be right for
Endometrial Cancer RecurrentEndometrial CancerAdvanced Endometrial Cancer+4 more
Outpace Bio, Inc. 30
Testing effectiveness (Phase 2)UnknownNCT03699449
What this trial is testing

An uMbrella Study of BIomarker-driven Targeted Therapy In Patients With Platinum-resistant Recurrent OvariaN Cancer(AMBITION)

Who this might be right for
Platinum-resistant Recurrent Ovarian Cancer
Yonsei University 104
Early research (Phase 1)Looking for participantsNCT06430541
What this trial is testing

Study of Psilocybin Assisted Psychotherapy to Address Fear of Recurrence

Who this might be right for
Breast CancerOvarian Cancer
University of Colorado, Denver 20
Early research (Phase 1)Ended earlyNCT01233505
What this trial is testing

Veliparib, Oxaliplatin, and Capecitabine in Treating Patients With Advanced Solid Tumors

Who this might be right for
Adenocarcinoma of the PancreasAdenocarcinoma of the StomachBRCA1 Mutation Carrier+23 more
National Cancer Institute (NCI) 16
Large-scale testing (Phase 3)Active Not RecruitingNCT01874353
What this trial is testing

Olaparib Treatment in BRCA Mutated Ovarian Cancer Patients After Complete or Partial Response to Platinum Chemotherapy

Who this might be right for
Platinum SensitiveBRCA MutatedRelapsed Ovarian Cancer+1 more
AstraZeneca 327
Testing effectiveness (Phase 2)UnknownNCT00703105
What this trial is testing

Ovarian Dendritic Cell Vaccine Trial

Who this might be right for
Ovarian Cancer
Loyola University 36
Large-scale testing (Phase 3)Study completedNCT03353831
What this trial is testing

Atezolizumab With Bevacizumab and Chemotherapy vs Bevacizumab and Chemotherapy in Early Relapse Ovarian Cancer

Who this might be right for
Recurrent Ovarian Carcinoma
AGO Research GmbH 574
Early research (Phase 1)Ended earlyNCT00303888
What this trial is testing

Docetaxel With or Without Phenoxodiol in Treating Patients With Recurrent Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer

Who this might be right for
Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer
Yale University 31
Large-scale testing (Phase 3)Looking for participantsNCT04921527
What this trial is testing

Chiauranib Plus Weekly Paclitaxel in Patients with Platinum-refractory or Platinum-resistant Recurrent Ovarian Cancer

Who this might be right for
Ovarian CancerRelapsed or RefractoryChiauranib+1 more
Chipscreen Biosciences, Ltd. 454
Testing effectiveness (Phase 2)Looking for participantsNCT04519151
What this trial is testing

Pembrolizumab and Lenvatinib for Platinum- Sensitive Recurrent Ovarian Cancer

Who this might be right for
Ovarian NeoplasmsCarcinoma, Ovarian EpithelialNeoplasm of Stomach+5 more
Sheba Medical Center 24
Testing effectiveness (Phase 2)Looking for participantsNCT07410494
What this trial is testing

Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors

Who this might be right for
CancerBreast CancerNon-Small Cell Lung Cancer (NSCLC)+10 more
Essen Biotech 85
Not applicableStudy completedNCT04546373
What this trial is testing

Niraparib as Maintenance Therapy in Patients With Platinum Sensitive Recurrent Ovarian Cancer

Who this might be right for
Epithelial Ovarian CancerFallopian Tube CancerPrimary Peritoneal Cancer
Grupo Español de Investigación en Cáncer de Ovario 316
Early research (Phase 1)Active Not RecruitingNCT01970722
What this trial is testing

Surgery and Chemotherapy With or Without Chemotherapy After Surgery in Treating Patients With Ovarian, Fallopian Tube, Uterine, or Peritoneal Cancer

Who this might be right for
FIGO Stage IVA Ovarian CancerFIGO Stage IVB Ovarian CancerPlatinum-Resistant Ovarian Carcinoma+26 more
City of Hope Medical Center 40
Not applicableUnknownNCT01851746
What this trial is testing

Docetaxel and Lobaplatin Versus Docetaxel and Carboplatin Combination Regimen in Patients With Platinum-sensitive (>6 Months) Relapsed Ovarian Cancer

Who this might be right for
Recurrent Ovarian Cancer
Wuhan University 200
Next Page